Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Compass Pathways Plc ADR (CMPS)

Compass Pathways Plc ADR (CMPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Vaccine Stocks Slide, Psychedelic Stocks Surge After RFK Jr. HHS Nomination

Markets sent a clear message Friday following President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to head the Department of Health and Human Services (HHS). Vaccine stocks took a nosedive,...

CMPS : 4.57 (-1.93%)
PSIL : 12.00 (-0.13%)
ATAI : 1.5600 (-1.89%)
AZN : 63.74 (+0.85%)
BVNRY : 9.0286 (+0.04%)
NVAX : 8.07 (+0.12%)
MRNA : 36.69 (-0.68%)
CYBN : 10.94 (-1.97%)
GSK : 33.30 (-0.15%)
PFE : 24.85 (-0.36%)
BNTX : 102.38 (+0.23%)
SNY : 47.73 (-0.10%)
Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript

CMPS earnings call for the period ending September 30, 2024.

CMPS : 4.57 (-1.93%)
Compass Pathways Plc (CMPS) Q2 2024 Earnings Call Transcript

CMPS earnings call for the period ending June 30, 2024.

CMPS : 4.57 (-1.93%)
1 Biotech Stock Under $10 That Could Surge 420%

Down 84% from all-time highs, Compass Pathways is a beaten-down biotech stock that trades at a massive discount to consensus price target estimates in 2024.

CMPS : 4.57 (-1.93%)
RY : 123.57 (+1.46%)
Should You Buy the Dip on Compass Pathways Stock?

Nothing is going wrong, but one of its peers just hit a serious snag.

CMPS : 4.57 (-1.93%)
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.

Regulators were not impressed by one company's petition for approval.

CMPS : 4.57 (-1.93%)
These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring

Psychedelic medicines are rapidly gaining legitimacy on several fronts.

CMPS : 4.57 (-1.93%)
Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Transcript

CMPS earnings call for the period ending March 31, 2024.

CMPS : 4.57 (-1.93%)
The Next Great Biotech Boom Has Arrived

EQNX::TICKER_START (NYSE:JNJ),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:ATAI),(NYSE:ABBV) EQNX::TICKER_END

JNJ : 153.33 (+0.14%)
CMPS : 4.57 (-1.93%)
MNMD : 7.26 (-3.46%)
ATAI : 1.5600 (-1.89%)
ABBV : 167.76 (+0.01%)
3 Biopharma Stocks You Don't Want to Miss in the New Bull Market

All three have exciting programs on the way.

VRTX : 447.24 (-0.88%)
CMPS : 4.57 (-1.93%)
CPRX : 21.05 (-0.47%)

Barchart Exclusives

Should You Buy This Nuclear Energy Stock Under $10?
ASP Isotopes is a nuclear energy stock priced under $10 that is positioned to deliver outsized gains to shareholders in the upcoming decade. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar